IRADIMED CORPORATION
DE ˙ DB ˙ US46266A1097
76,50 € ↓ -1,50 (-1,92%)
2026-06-03
AKTIENPREIS
SecurityDE:46K / IRADIMED CORPORATION
InstitutionBarclays Plc
Latest Disclosed Ownership25,849 shares
Latest Disclosed Value $ 2,514,591
Barclays Plc reports 7.76% increase in ownership of 46K / IRADIMED CORPORATION

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 25,849 shares of IRADIMED CORPORATION (DE:46K) valued at $2,132,542 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 23,987 shares of IRADIMED CORPORATION. This represents a change in shares of 7.76% during the quarter. The current value of the position is $1,977,448 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F IRADIMED COM 46266A109 25,849 1,862 7.76 2,515 47.36 0.0006
2026-03-31 2025-09-30 13F/A-3 IRADIMED COM 46266A109 23,987 -3,229 -11.86 1,707 4.86 0.0004
2026-03-19 2025-09-30 13F/A-2 IRADIMED COM 46266A109 23,774 -3,442 1,196 0.0003
2025-11-12 2025-09-30 13F IRADIMED COM 46266A109 23,987 -3,229 1,707 0.0004
2026-02-27 2025-06-30 13F/A-2 IRADIMED COM 46266A109 27,216 6,501 31.38 1,627 49.68 0.0004
2025-08-14 2025-06-30 13F/A-1 IRADIMED COM 46266A109 27,216 6,501 2 0.0004
2025-08-13 2025-06-30 13F IRADIMED COM 46266A109 27,216 6,501 2 0.0001
2026-03-17 2025-03-31 13F/A-1 IRADIMED COM 46266A109 20,715 -4,401 -17.52 1,087 -21.29 0.0003
2025-05-15 2025-03-31 13F IRADIMED COM 46266A109 20,715 -4,401 1 0.0003
2026-03-19 2024-12-31 13F/A-1 IRADIMED COM 46266A109 25,116 1,342 5.64 1,381 15.56 0.0004
2025-02-13 2024-12-31 13F IRADIMED COM 46266A109 25,116 1,342 1 0.0004
2026-03-31 2024-09-30 13F/A-2 IRADIMED COM 46266A109 23,774 12,657 113.85 1,196 144.88 0.0003
2024-11-19 2024-09-30 13F/A-1 IRADIMED COM 46266A109 23,774 12,657 1 0.0003
2024-11-15 2024-09-30 13F IRADIMED COM 46266A109 23,774 12,657 1 0.0001
2026-03-23 2024-06-30 13F/A-1 IRADIMED COM 46266A109 11,117 -3,635 -24.64 488 -24.69 0.0001
2024-08-14 2024-06-30 13F IRADIMED COM 46266A109 11,117 -3,635 0 0.0001
2026-03-24 2024-03-31 13F/A-1 IRADIMED COM 46266A109 14,752 -4,766 -24.42 649 -30.02 0.0002
2024-05-15 2024-03-31 13F IRADIMED COM 46266A109 14,752 -4,766 1 0.0002
2026-03-25 2023-12-31 13F/A-1 IRADIMED COM 46266A109 19,518 8,862 83.16 927 96.19 0.0003
2024-02-15 2023-12-31 13F IRADIMED COM 46266A109 19,518 8,862 1 0.0003
2026-03-26 2023-09-30 13F/A-1 IRADIMED COM 46266A109 10,656 3,203 42.98 473 32.96 0.0003
2023-11-07 2023-09-30 13F IRADIMED COM 46266A109 10,656 3,203 0 0.0003
2026-03-30 2023-06-30 13F/A-2 IRADIMED COM 46266A109 7,453 -2,049 -21.56 356 -4.83 0.0002
2023-09-20 2023-06-30 13F/A-1 IRADIMED COM 46266A109 7,453 -2,049 0 0.0002
2023-08-03 2023-06-30 13F IRADIMED COM 46266A109 7,453 -2,049 0 0.0002
2026-03-30 2023-03-31 13F/A-1 IRADIMED COM 46266A109 9,502 1,856 24.27 374 72.69 0.0002
2023-05-04 2023-03-31 13F IRADIMED COM 46266A109 9,502 1,856 0 0.0002
2026-03-30 2022-12-31 13F/A-1 IRADIMED COM 46266A109 7,646 2,587 51.14 216 42.11 0.0001
2023-02-13 2022-12-31 13F IRADIMED COM 46266A109 7,646 2,587 0 0.0001
2022-11-03 2022-09-30 13F IRADIMED COM 46266A109 5,059 -56 -1.09 152 -12.14 0.0002
2022-08-12 2022-06-30 13F IRADIMED COM 46266A109 5,115 -13,273 -72.18 173 -79.03 0.0001
2022-05-16 2022-03-31 13F IRADIMED COM 46266A109 18,388 4,309 30.61 825 26.92 0.0006
2022-02-23 2021-12-31 13F/A-1 IRADIMED COM 46266A109 14,079 5,104 56.87 650 115.95 0.0002
2022-02-14 2021-12-31 13F IRADIMED COM 46266A109 14,079 5,104 650 0.0002
2021-11-09 2021-09-30 13F IRADIMED COM 46266A109 8,975 1,791 24.93 301 41.98 0.0001
2021-08-13 2021-06-30 13F IRADIMED COM 46266A109 7,184 -4,117 -36.43 212 -26.90 0.0001
2021-05-13 2021-03-31 13F IRADIMED COM 46266A109 11,301 1,641 16.99 290 31.82 0.0002
2021-02-11 2020-12-31 13F IRADIMED COM 46266A109 9,660 -509 -5.01 220 1.85 0.0001
2020-11-12 2020-09-30 13F IRADIMED COM 46266A109 10,169 -2,753 -21.30 216 -27.76 0.0001
2020-08-12 2020-06-30 13F IRADIMED COM 46266A109 12,922 8,553 195.77 299 221.51 0.0002
2020-05-13 2020-03-31 13F IRADIMED COM 46266A109 4,369 -2,993 -40.65 93 -45.61 0.0001
2020-02-10 2019-12-31 13F IRADIMED COM 46266A109 7,362 2,010 37.56 171 51.33 0.0001
2019-11-15 2019-09-30 13F/A-1 IRADIMED COM 46266A109 5,352 2,509 88.25 113 94.83 0.0001
2019-11-14 2019-09-30 13F IRADIMED COM 46266A109 5,352 2,509 113 26.1257
2019-08-14 2019-06-30 13F IRADIMED COM 46266A109 2,843 -53 -1.83 58 -29.27 0.0000
2019-05-15 2019-03-31 13F IRADIMED COM 46266A109 2,896 837 40.65 82 64.00 0.0001
2019-02-14 2018-12-31 13F IRADIMED COM 46266A109 2,059 721 53.89 50 0.00 0.0000
2018-11-14 2018-09-30 13F IRADIMED COM 46266A109 1,338 237 21.53 50 108.33 0.0000
2018-08-14 2018-06-30 13F IRADIMED COM 46266A109 1,101 1,087 7,764.29 24 0.0000
2018-05-15 2018-03-31 13F IRADIMED COM 46266A109 14 -1,305 -98.94 0 -100.00
2017-05-15 2017-03-31 13F IRADIMED COM 46266A109 1,319 1,152 689.82 12 500.00 0.0000
2017-02-14 2016-12-31 13F IRADIMED COM 46266A109 167 130 351.35 2 100.00 0.0000
2016-11-14 2016-09-30 13F IRADIMED COM 46266A109 37 37 0.00 1 0.0000
2016-05-16 2016-03-31 13F IRADIMED COM 46266A109 0 -19,177 -100.00 0 -100.00
2016-02-12 2015-12-31 13F IRADIMED COM 46266A109 19,177 13,862 260.81 537 322.83 0.0007
2015-11-13 2015-09-30 13F IRADIMED COM 46266A109 5,315 5,261 9,742.59 127 12,600.00 0.0002
2015-08-14 2015-06-30 13F IRADIMED COM 46266A109 54 54 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.